Priti desai - M.Sc., Ph.D. in Biochemistry More than 13 years post PhD work experience as a scientist and professor Worked with Cadila Pharmaceuticals ltd., B.V. Patel PERD Centre- Ahmedabad, NIPER-Ahmedabad, and Institute of Advanced Research (IAR), Gandhinagar Developed platform technology for oral/mucosal vaccine Completed various government and nongovernment research grants in the area of vaccines and Biotherapeutics Research is well recognized at international and national levels which is evident by research papers published in many internationally recognized journals and various awards at the international level Currently exploring the possibilities for start-ups in the area of vaccine & Biotherapeutics

Priti desai

M.Sc., Ph.D. in Biochemistry More than 13 years post PhD work experience as a scientist and professor Worked with Cadila Pharmaceuticals ltd., B.V. Patel PERD Centre- Ahmedabad, NIPER-Ahmedabad, and Institute of Advanced Research (IAR), Gandhinagar Developed platform technology for oral/mucosal vaccine Completed various government and nongovernment research grants in the area of vaccines and Biotherapeutics Research is well recognized at international and national levels which is evident by research papers published in many internationally recognized journals and various awards at the international level Currently exploring the possibilities for start-ups in the area of vaccine & Biotherapeutics

More about Priti desai

Dr Priti Desai (M.Sc. PhD) is a co-founder of NIRAV Holdings, a company looking to invest in diverse portfolio of startups and MSMEs. NIRAV HOLDINGS aim to provide handhold companies with guidance and financial support to promising start-up in the field of healthcare particularly biopharma.
She has vast experience in product-oriented research as well as in teaching and administration. She was previously associated with Institute of Advanced Research (IAR), Gandhinagar and B.V. Patel PERD centre, Ahmedabad where she served role as HOD (Biotechnology), Assistant professor and scientist respectively.
During her research journey in PERD and IAR, she had developed oral mucosal vaccine against shigella and demonstrated its protective efficacy using in-house developed murine model. Her research work was recognised by many prestigious international and national scientific bodies in the form awards, research grants (from central governments) and research papers published in highly recognised international scientific journals.

Preferred eChai Business Partners

The eChai Preferred Business Partners program enables businesses more visibility within the eChai Network through an annual subscription.

MICAverse
FirstSales.io
LegalWiz.in
Brands.live
Pro Zero Carbon
Growth Iris
Creatosaurus
Netcore for Startups
ZenDevX
Candour Legal
Allevents
Hearty Mart
The Headquarters
Mantras2Success
58Miles
IBGrid
Draper Startup House
Biziverse
Because
STIR Advisors
CoKarma
Zepul
DevX
Redicine Medsol
Narayana Business School
Timechain Labs
ES Healthcare Centre
About eChai Business Partner Program:

Key benefits:

  • Listing on preferred eChai Business Partners page (1 year duration)
  • Engagement at relevant in-person eChai Meetups (~4 meetups/year)
  • Feature on eChai.Ventures

eChai Ventures is a friendly global startup network that hosts engaging Startup Growth meetups in 10+ Countries and enables cross-border collaborations.

You can reach out to Jatin Chaudhary, Co-Founder, eChai Ventures over WhatsApp or over email at [email protected] to explore more about it.